GeneDx Holdings Corp. (WGS)
NASDAQ • Healthcare
Last close at November 20, 2026 at 21:00 UTC
Metrics Over Time
Where the Money Goes
Q3 2026In plain terms: out of every $100 in revenue, GeneDx Holdings Corp. currently loses $10.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
GeneDx’s adjusted EPS topped expectations while revenue came in line in the third fiscal quarter of 2026, reported November 9, 2026, with revenue rising 5.4% to about $123.1 million (up from roughly $116.7 million a year ago). On the consensus view, adjusted EPS of $0.28 topped the $0.07 estimate by $0.21, while revenue of $123.1 million was in line with the $122.9 million estimate (+0.1%). Profitability was supported by gross profit of about $86.1 million, with gross margin near 70%, but the company still posted operating income of roughly -$10.4 million as operating margin stood at about -9%. Net income fell 61.5% year over year to around -$12.3 million (down from roughly -$7.6 million a year ago). Cash generation remained negative, with negative operating cash flow of about -$10.6 million. For the next period, consensus calls for EPS of $0.31 on revenue of $142.6 million.
About GeneDx Holdings Corp.
GeneDx Holdings Corp. provides genomic testing and data-driven research tools in healthcare and trades on the NASDAQ under WGS. The company uses large clinical and genomic datasets to support diagnostic and research work, and it generated $427.5 million of revenue in FY2025.
Today's Snapshot
WGS closed 7.7% below yesterday's close, while its sector was flat. Shares changed hands at about half of its usual level. GeneDx Holdings changed its CEO, a leadership change at the genetic-testing company.
Trading Volume
Below 10d avg (1.5M)
772.8K
vs S&P 500 Today
Strong Underperformance
-4.19%
Updated: November 20, 2026 at 21:08 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$52.37 - $78.22Sell
- RSI (14)33.52Neutral
- Stochastic %K (14, 3, 3)17.29Buy
- MACD Level (12, 26)-5.99Sell
Peers & Related Assets
Get premium market insights delivered directly to your inbox.